The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.
 
Benjamin R. Tan
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); TYME (Inst)
 
Thatthan Suksombooncharoen
No Relationships to Disclose
 
Hidenori Takahashi
Research Funding - AstraZeneca; Daiichi Sankyo; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Ming-Huang Chen
No Relationships to Disclose
 
Vikas S Ostwal
Research Funding - BDR Pharmaceutics (Inst); Cadila Pharmaceuticals (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Lupin Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Sang Cheul Oh
No Relationships to Disclose
 
Emel Sezer
No Relationships to Disclose
 
Piotr Potemski
Consulting or Advisory Role - AstraZeneca; MSD; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck
Research Funding - AstraZeneca; Roche
 
Kun-Ming Rau
No Relationships to Disclose
 
Ekaphop Sirachainan
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim (I); Bristol-Myers Squibb; Diethelm Keller Group; Dr. Reddy's Laboratories; LF Asia; Meda Pharmaceuticals; Merck; MSD; Mundipharma; Novartis (I); Novo Nordisk (I); Pfizer; Roche; Roche (I); Sanofi/Aventis; Taiho Pharmaceutical; Zuellig Pharma
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD Oncology; Novartis; Roche; Taiho Oncology
Travel, Accommodations, Expenses - American Taiwan Biopharm; Amgen; AstraZeneca; Eisai; MSD; Pfizer; Taiho Pharmaceutical
 
Junhe Li
No Relationships to Disclose
 
Jean-Frédéric Blanc
Honoraria - AstraZeneca; Bayer Schering Pharma; Eisai; INCYTE; IPSEN; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IPSEN; ROCHE; SERVIER
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Gordon Cohen
No Relationships to Disclose
 
Magdalena Żotkiewicz
Employment - AstraZeneca
 
Nana Rokutanda
Employment - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Do-Youn Oh
Consulting or Advisory Role - Arcus Biosciences; ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; IQVIA; Merck Serono; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER